2901 |
6U9S |
AB_C |
5A6 Fab |
CD81 antigen |
Mus musculus, Homo sapiens |
XRD |
2.4 | 10.7554/eLife.52337 |
2902 |
6U9S |
DE_F |
5A6 Fab |
CD81 antigen |
Mus musculus, Homo sapiens |
XRD |
2.4 | 10.7554/eLife.52337 |
2903 |
6UC6 |
C_A |
JLI-H11 VHH |
Botulinum neurotoxin type B receptor-binding domain |
Clostridium botulinum, Vicugna pacos |
XRD |
2.32 | 10.1016/j.celrep.2020.01.107 |
2904 |
6UC6 |
D_B |
JLI-H11 VHH |
Botulinum neurotoxin type B receptor-binding domain |
Clostridium botulinum, Vicugna pacos |
XRD |
2.32 | 10.1016/j.celrep.2020.01.107 |
2905 |
6UDA |
CD_A |
CH235 UCA Fab |
HIV-1 CH505.N279K.G458Y.SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
4.2 | 10.1371/journal.ppat.1008026 |
2906 |
6UDA |
GH_E |
CH235 UCA Fab |
HIV-1 CH505.N279K.G458Y.SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
4.2 | 10.1371/journal.ppat.1008026 |
2907 |
6UDA |
KL_I |
CH235 UCA Fab |
HIV-1 CH505.N279K.G458Y.SOSIP.664 gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
4.2 | 10.1371/journal.ppat.1008026 |
2908 |
6UDK |
AB_G |
10-1074 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1016/j.cell.2020.01.010 |
2909 |
6UDK |
OP_R |
10-1074 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1016/j.cell.2020.01.010 |
2910 |
6UDK |
FI_K |
10-1074 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1016/j.cell.2020.01.010 |
2911 |
6UDK |
HL_K |
1-55 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1016/j.cell.2020.01.010 |
2912 |
6UDK |
DE_G |
1-55 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1016/j.cell.2020.01.010 |
2913 |
6UDK |
MN_R |
1-55 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
3.9 | 10.1016/j.cell.2020.01.010 |
2914 |
6UFT |
B_A |
JLK-G12 VHH |
Botulinum neurotoxin type B receptor-binding domain |
Clostridium botulinum, Vicugna pacos |
XRD |
2.9 | 10.1016/j.celrep.2020.01.107 |
2915 |
6UHT |
C_A |
JLI-G10 VHH |
Botulinum neurotoxin type B receptor-binding domain |
Clostridium botulinum, Vicugna pacos |
XRD |
2.2 | 10.1016/j.celrep.2020.01.107 |
2916 |
6UHT |
D_B |
JLI-G10 VHH |
Botulinum neurotoxin type B receptor-binding domain |
Clostridium botulinum, Vicugna pacos |
XRD |
2.2 | 10.1016/j.celrep.2020.01.107 |
2917 |
6UI1 |
B_A |
ciA-H7 VHH |
Botulinum Neurotoxins |
Clostridium botulinum, Vicugna pacos |
XRD |
2.2 | 10.1016/j.celrep.2020.01.107 |
2918 |
6UI1 |
C_A |
ciA-D12 VHH |
Botulinum Neurotoxins |
Clostridium botulinum, Vicugna pacos |
XRD |
2.2 | 10.1016/j.celrep.2020.01.107 |
2919 |
6UI1 |
D_A |
ciA-B5 VHH |
Botulinum Neurotoxins |
Clostridium botulinum, Vicugna pacos |
XRD |
2.2 | 10.1016/j.celrep.2020.01.107 |
2920 |
6UIG |
HL_G |
H7.200 Fab |
Influenza A virus H7N9 hemagglutinin |
Influenza A virus, Homo sapiens |
XRD |
3.2 | 10.1172/JCI136032 |